Your browser doesn't support javascript.
The Impact of the SARS-CoV-2 Pandemic in PID Patients Receiving Ig Replacement Therapy.
Cekic, Sukru; Cicek, Fatih; Kilic, Sara Sebnem.
  • Cekic S; Department of Pediatrics, Division of Immunology and Rheumatology, Bursa Uludag University Faculty of Medicine, Bursa, Turkey.
  • Cicek F; Department of Pediatrics, Division of Immunology and Rheumatology, Bursa Uludag University Faculty of Medicine, Bursa, Turkey.
  • Kilic SS; Department of Pediatrics, Division of Immunology and Rheumatology, Bursa Uludag University Faculty of Medicine, Bursa, Turkey. sebnemkl@uludag.edu.tr.
J Clin Immunol ; 41(4): 733-737, 2021 05.
Article in English | MEDLINE | ID: covidwho-1384519
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Quality of Life / Immunoglobulins / Immunocompromised Host / Primary Immunodeficiency Diseases / COVID-19 Type of study: Experimental Studies / Observational study / Prognostic study / Qualitative research / Randomized controlled trials Limits: Adolescent / Adult / Aged / Child / Child, preschool / Female / Humans / Infant / Male / Middle aged Language: English Journal: J Clin Immunol Year: 2021 Document Type: Article Affiliation country: S10875-020-00958-5

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Quality of Life / Immunoglobulins / Immunocompromised Host / Primary Immunodeficiency Diseases / COVID-19 Type of study: Experimental Studies / Observational study / Prognostic study / Qualitative research / Randomized controlled trials Limits: Adolescent / Adult / Aged / Child / Child, preschool / Female / Humans / Infant / Male / Middle aged Language: English Journal: J Clin Immunol Year: 2021 Document Type: Article Affiliation country: S10875-020-00958-5